| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5698428 | Clinical Oncology | 2013 | 8 Pages |
Abstract
Universal guidance is lacking in the management of non-operable irradiated recurrent ependymoma and there are worthy therapeutic avenues for further investigation, in particular the role of radical re-irradiation and also the potential of bevacizumab in advanced disease. It is hoped that advances can be achieved by multicentre collaboration in future studies to overcome the difficulties posed by achieving meaningful data in such a rare tumour with extensive natural history.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Muhammad Shahid Iqbal, Joanne Lewis,